Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Adverse drug effects

Birth defect risk unaffected by exposure to oral contraceptives

Researchers conclude that exposure to oral contraceptives is ‘unlikely’ to cause major birth defects following nationwide study.

Oral contraceptive exposure just before or during pregnancy appears not to be associated with an increased risk of major birth defects, researchers report. In the image, close up of a woman taking oral contraceptives


Researchers found no increased risk of major birth defects associated with oral contraceptive use in the months just before or after the onset of pregnancy

Oral contraceptive exposure just before or during pregnancy is not associated with an increased risk of major birth defects, according to results of a Danish study.

“This study is further evidence of exposure to oral contraceptives not being associated with an increased risk of major birth defects,” says Natika Halil, chief executive of UK sexual health charity FPA, which welcomes the research. “Previous research had also shown there to be no consistent findings of specific fetal abnormalities,” she adds.

Although several studies have showed no risk associated with oral contraceptive use before or during pregnancy and the health of the offspring, the link has been unclear for some years, the researchers say. In particular, it was unclear how long the effects of the circulating sex hormones released by the pills might last.

Exogenous sex hormones have been shown to increase plasma concentrations of vitamin A, which is known to cause birth defects. Studies also suggest that serum levels of the B vitamin folate are reduced after oral contraceptive use and remain reduced for up to three months after discontinuation, which could also lead to a range of birth defects.

The researchers, led by Brittany Charlton of the Harvard TH Chan School of Public Health in Boston, Massachusetts, ran a nationwide study in Denmark to investigate whether oral contraceptive use less than three months before pregnancy was associated with an increased risk of major birth defects. Data were collected from 880,694 infants, 2.5% of whom had a major birth defect, such as an orofacial cleft or limb defect, within the first year of life.

The team found no increased risk of major birth defects associated with oral contraceptive use in the months just before or after the onset of pregnancy. The prevalence of major birth defects (per 1,000 births) was consistent across each of the oral contraceptive exposure groups: 25.1 for mothers who had never used oral contraceptives; 25.0 for mothers who had only used oral contraceptives more than three months before pregnancy onset; 24.9 for mothers who used oral contraceptives less than three months before pregnancy onset; and 24.8 for those who had continued to use oral contraceptives after pregnancy onset.

There was also no increase in the prevalence of any birth defect subgroup (for example, limb defects), although the authors warn that the rarity of birth defects made disaggregation of the results difficult.

“For women who have a breakthrough pregnancy during oral contraceptive use, or even intentionally become pregnant within a few months of stopping oral contraceptive use, any exposure is unlikely to cause her fetus to develop a major birth defect,” say the researchers, whose results were published in the BMJ[1] on 7 January 2016.

Oral contraceptives are known to be more than 99% effective when the correct regimen is followed, but around 9% of women become pregnant in the first year of use because either they have missed a dose, taken the pill with other medications, or have been ill.

“In reality, inadvertent exposure to contraceptive hormones can be quite common, especially when there is a delay in a pregnancy being confirmed. For example, if amenorrhoea [abnormal absence of menstruation] is assumed to be due to the contraceptive method, or if bleeding is mistaken for a period,” says the FPA’s Halil.

The findings make an important addition to patient care in this area, she adds. “Health professionals can offer further reassurance to women who may worry about potential effects during pregnancy.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200433

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • Traditional Medicine

    Traditional Medicine

    Covers the major traditional medicine systems. Gives information on philosophy, practice, safety, evidence and examples.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £28.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The contraceptive pill has been trumpeted as a major development of the modern world.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.